Immunological Mechanisms by Which Concomitant Helminth Infections Predispose to the Development of Human Tuberculosis.
- Author:
Patricia MENDEZ-SAMPERIO
1
Author Information
1. Departamento de Inmunologia, Escuela Nacional de Ciencias Biologicas, IPN, Prol. Carpio y Plan de Ayala, Mexico, D.F. 11340 Mexico. pmendezs@encb.ipn.mx
- Publication Type:Review
- Keywords:
helminth;
immune response;
mycobacterial infection;
tuberculosis
- MeSH:
Animals;
Coinfection;
Helminthiasis/complications/*immunology/parasitology;
Helminths/*immunology;
Humans;
Mycobacterium tuberculosis/*immunology;
Tuberculosis/complications/*immunology/microbiology
- From:The Korean Journal of Parasitology
2012;50(4):281-286
- CountryRepublic of Korea
- Language:English
-
Abstract:
Helminthic infections afflict over 1.5 billion people worldwide, while Mycobacterium tuberculosis infects one third of the world's population, resulting in 2 million deaths per year. Although tuberculosis and helminthic infections coexist in many parts of the world, and it has been demonstrated that the T-helper 2 and T-regulatory cell responses elicited by helminths can affect the ability of the host to control mycobacterial infection, it is still unclear whether helminth infections in fact affect tuberculosis disease. In this review article, current progress in the knowledge about the immunomodulation induced by helminths to diminish the protective immune responses to bacille Calmette-Guerin vaccination is reviewed, and the knowledge about the types of immune responses modulated by helminths and the consequences for tuberculosis are summarized. In addition, recent data supporting the significant reduction of both M. tuberculosis antigen-specific Toll-like receptor (TLR) 2 and TLR9 expression, and pro-inflammatory cytokine responses to TLR2 and TLR9 ligands in individuals with M. tuberculosis and helminth co-infection were discussed. This examination will allow to improve understanding of the immune responses to mycobacterial infection and also be of great relevance in combating human tuberculosis.
